Dermatology

Abeona Therapeutics has announced one year data from Cohort 1 of the ongoing ABO-102 Phase 1/2 trial for Sanfilippo syndrome Type A (MPS IIIA).

Cell therapy meets gene therapy to advance dermatology

Application is based on clinical trial results from the Phase 3 ALCANZA and Phase 2 investigator-sponsored studies in cutaneous T cell lymphoma

A collection of recent regulatory approvals and other actions globally

Preclinical data show Novan’s SB414 could be promising for treating psoriasis

The Mumbai, India-based company has acquired Odomzo from Novartis for $175M

Purdue Pharma links up with Exicure in agreement to apply Exicure's SNA technology

Pivotal data show statistically significant results, meeting all primary and secondary endpoints for treating the common yet undertreated skin condition

Abeona engages in partnership for EB gene therapy treatments

New ‘second skin’ polymer material could not only protect dry skin but also might prove useful in delivering drugs

Safety and efficacy data from latest clinical trial confirm results from previous Phase 2a trial; DRM01 Phase 3 clinical program planning now underway

Allergan paid $85 million in an upfront payment and success-based development and sales milestones for XAF5